Cargando…

Differential effects of cotreatment of the antibiotic rifampin with host-directed therapeutics in reducing intracellular Staphylococcus aureus infection

BACKGROUND: Chronic infection by Staphylococcus aureus drives pathogenesis in important clinical settings, such as recurrent pulmonary infection in cystic fibrosis and relapsing infection in osteomyelitis. Treatment options for intracellular S. aureus infection are limited. Rifampin, a lipophilic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, Melissa D., Sammelson, Robert, McDowell, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2020
Materias:	Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664464/ https://www.ncbi.nlm.nih.gov/pubmed/33240647 http://dx.doi.org/10.7717/peerj.10330

Ejemplares similares

Pleiotropic Effects of Statins: New Therapeutic Approaches to Chronic, Recurrent Infection by Staphylococcus aureus
por: Evans, Melissa D., et al.
Publicado: (2021)

Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir
por: Rabie, Helena, et al.
Publicado: (2020)

Innovations in Evaluating Statin Benefit and Efficacy in Staphylococcus aureus Intracellular Infection Management
por: Nesson, Erik T., et al.
Publicado: (2022)

Identification of novel targets for host-directed therapeutics against intracellular Staphylococcus aureus
por: Bravo-Santano, Natalia, et al.
Publicado: (2019)

Characterization of rifampin-resistant Staphylococcus aureus nasal carriage in patients receiving rifampin-containing regimens for tuberculosis
por: Huang, Yu-Tsung, et al.
Publicado: (2018)

Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus
por: Bravo-Santano, Natalia, et al.
Publicado: (2019)

Ultrasonically enhanced rifampin activity against internalized Staphylococcus aureus
por: SHI, SI-FENG, et al.
Publicado: (2013)

Evaluation of Staphylococcal Bacteriophage Sb-1 as an Adjunctive Agent to Antibiotics Against Rifampin-Resistant Staphylococcus aureus Biofilms
por: Wang, Lei, et al.
Publicado: (2020)

Intracellular Staphylococcus aureus persisters upon antibiotic exposure
por: Peyrusson, Frédéric, et al.
Publicado: (2020)

Host-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus
por: Bravo-Santano, Natalia, et al.
Publicado: (2019)

Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
por: Greimel, Felix, et al.
Publicado: (2017)

Comparison of Staphylococcus aureus tolerance between antimicrobial blue light, levofloxacin, and rifampin
por: Ong, Jemi, et al.
Publicado: (2023)

Intracellular delivery of therapeutic proteins. New advancements and future directions
por: Porello, Ilaria, et al.
Publicado: (2023)

Therapeutic utility of glucocorticoids and antihistamines cotreatment. Rationale and perspectives
por: Zappia, Carlos D., et al.
Publicado: (2019)

Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant Staphylococcus aureus
por: Guérillot, Romain, et al.
Publicado: (2018)

Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis
por: Ma, Huan, et al.
Publicado: (2020)

Zirconyl Clindamycinphosphate Antibiotic Nanocarriers for Targeting Intracellular Persisting Staphylococcus aureus
por: Heck, Joachim G., et al.
Publicado: (2018)

Adjunctive Use of Phage Sb-1 in Antibiotics Enhances Inhibitory Biofilm Growth Activity versus Rifampin-Resistant Staphylococcus aureus Strains
por: Wang, Lei, et al.
Publicado: (2020)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Effectiveness and Optimal Duration of Adjunctive Rifampin Treatment in the Management of Staphylococcus aureus Prosthetic Joint Infections After Debridement, Antibiotics, and Implant Retention
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus
por: Yang, Xiaohong, et al.
Publicado: (2018)

Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
por: Mirzaei, Rasoul, et al.
Publicado: (2022)

Anti-methicillin-resistant Staphylococcus aureus and antibiofilm activity of new peptides produced by a Brevibacillus strain
por: Ogunsile, Abiodun, et al.
Publicado: (2023)

Intracellular Staphylococcus aureus Modulates Host Central Carbon Metabolism To Activate Autophagy
por: Bravo-Santano, Natalia, et al.
Publicado: (2018)

Equisetin Targets Intracellular Staphylococcus aureus through a Host Acting Strategy
por: Tian, Jiayao, et al.
Publicado: (2022)

Rifampin-Resistant Cutibacterium (formerly Propionibacterium) namnetense Superinfection after Staphylococcus aureus Bone Infection Treatment
por: Corvec, Stéphane, et al.
Publicado: (2018)

Molecular Characteristics and Prevalence of Rifampin Resistance in Staphylococcus aureus Isolates from Patients with Bacteremia in South Korea
por: Kim, Yong Kyun, et al.
Publicado: (2023)

Lactococcus lactis secreting phage lysins as a potential antimicrobial against multi-drug resistant Staphylococcus aureus
por: Chandran, Carumathy, et al.
Publicado: (2022)

Therapy of intracellular Staphylococcus aureus by tigecyclin
por: Kreis, Carolin A, et al.
Publicado: (2013)

The Synergistic Effect of Nicotine and Staphylococcus aureus on Peri-Implant Infections
por: Hu, Yao, et al.
Publicado: (2021)

Recent Advances in Aptasensors For Rapid and Sensitive Detection of Staphylococcus Aureus
por: Chen, Wei, et al.
Publicado: (2022)

The Use of Acute Immunosuppressive Therapy to Improve Antibiotic Efficacy against Intracellular Staphylococcus aureus
por: Beam, Jenna E., et al.
Publicado: (2022)

Rifampin phosphotransferase is an unusual antibiotic resistance kinase
por: Stogios, Peter J., et al.
Publicado: (2016)

Intracellular staphylococcus aureus: Live-in and let die
por: Fraunholz, Martin, et al.
Publicado: (2012)

Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly
por: Krauss, Jennifer L., et al.
Publicado: (2019)

Delayed Rifampin Administration in the Antibiotic Treatment of Periprosthetic Joint Infections Significantly Reduces the Emergence of Rifampin Resistance
por: Darwich, Ali, et al.
Publicado: (2021)

Intracellular Penetration and Effects of Antibiotics on Staphylococcus aureus Inside Human Neutrophils: A Comprehensive Review
por: Bongers, Suzanne, et al.
Publicado: (2019)

Adjunctive rifampin therapy for native valve Staphylococcus aureus endocarditis in a neonate: A case report and literature review
por: Almatrafi, Mohammed A., et al.
Publicado: (2021)

Molecular Characteristics of Rifampin-Sensitive and -Resistant Isolates and Characteristics of rpoB Gene Mutations in Methicillin-Resistant Staphylococcus aureus
por: Guo, Yinjuan, et al.
Publicado: (2021)

Intracellular Staphylococcus aureus Perturbs the Host Cell Ca(2+) Homeostasis To Promote Cell Death
por: Stelzner, Kathrin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pscmvofjon17uhr2tc848h54b4